FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study
Clinical trial NCT05639543 · TERMINATED
Trial details
- NCT number
- NCT05639543
- Sponsor
- Intercept Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2026-02-10
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.